← Open Payments lookup

ZIAD SAWI: Open Payments

NPI 1194725127 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$860 in 43 payments from 8 companies in 2025. Trend: 2023 $604 · 2024 $957 · 2025 $860

Food & beverage: $860
CompanyPaymentsAmount
Forte Bio-Pharma LLC14$320
Salix Pharmaceuticals, a division of Bausch Health US, LLC14$230
Collegium Pharmaceutical, Inc.5$103
PROTEGA PHARMACEUTIALS INC4$81
IBSA Pharma Inc.3$63
ABBVIE INC.1$24
PFIZER INC.1$23
SCILEX PHARMACEUTICALS INC.1$16

Products named: PROLATE, RELISTOR, ROXYBOND, XTAMPZA, Tirosint, Belbuca, UBRELVY, NURTEC ODT.

Industry payments across NV — which companies pay providers there.